This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The $2,535.06 delivery order is for the pharmaceutical product Pulmozyme, a medication used to treat cystic fibrosis. The contract has a ceiling value of $2,535.06 and a completion date of December 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. The DLA, a defense agency, is the funding agency for this contract, which supports the procurement of essential medical supplies and pharmaceuticals for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/12/25, 9:57 AM